Correction

Published on 16 May 2024

Corrigendum: Mechanotransductive receptor Piezo1 as a promising target in the treatment of fibrosis diseases

in Molecular Diagnostics and Therapeutics

Yi Xu
Yiqian Huang
Xiaoqing Cheng
Bin Hu
Danling Jiang
Lidong Wu
Shengliang Peng
Jialing Hu

Frontiers in Molecular Biosciences

doi 10.3389/fmolb.2024.1420585

845 views

Original Research

Published on 15 May 2024

MicroRNA as a promising molecular biomarker in the diagnosis of breast cancer

in Molecular Diagnostics and Therapeutics

Felipe Silva de Miranda
José Slaibi-Filho
Gabriel Calasans dos Santos
Nathalia Teixeira Carmo
Carla Martins Kaneto
Thaiz Ferraz Borin
Wilson Barros Luiz
Luciene Cristina Gastalho Campos

Frontiers in Molecular Biosciences

doi 10.3389/fmolb.2024.1337706

1,887 views
1 citation

Review

Published on 14 May 2024

Circulating microRNAs as promising diagnostic biomarkers for hepatocellular carcinoma: a systematic review and meta-analysis

in Molecular Diagnostics and Therapeutics

Ermiyas Alemayehu
Alebachew Fasil
Hussen Ebrahim
Zewudu Mulatie
Getachew Mesfin Bambo
Alemu Gedefie
Mulugeta Teshome
Abebaw Worede
Melaku Ashagrie Belete

Frontiers in Molecular Biosciences

doi 10.3389/fmolb.2024.1353547

1,814 views
1 citation

Review

Published on 09 May 2024

Next generation single-domain antibodies against respiratory zoonotic RNA viruses

in Molecular Diagnostics and Therapeutics

Iris C. Swart
Willem Van Gelder
Cornelis A. M. De Haan
Berend-Jan Bosch
Sabrina Oliveira

Frontiers in Molecular Biosciences

doi 10.3389/fmolb.2024.1389548

1,621 views
1 citation

Original Research

Published on 07 May 2024

Multikinase inhibitors modulate non-constitutive proteasome expression in colorectal cancer cells

in Molecular Diagnostics and Therapeutics

Alexander Burov
Ekaterina Grigorieva
Timofey Lebedev
Valeria Vedernikova
Vladimir Popenko
Tatiana Astakhova
Olga Leonova
Pavel Spirin
Vladimir Prassolov
Vadim Karpov

Frontiers in Molecular Biosciences

doi 10.3389/fmolb.2024.1351641

1,354 views
1 citation

Review

Published on 06 May 2024

Prospects of liquid biopsy in the prognosis and clinical management of gastrointestinal cancers

in Molecular Diagnostics and Therapeutics

Deepankar Mondal
Sapnita Shinde
Vibha Sinha
Vineeta Dixit
Souvik Paul
Rakesh Kumar Gupta
Suresh Thakur
Naveen Kumar Vishvakarma
Dhananjay Shukla

Frontiers in Molecular Biosciences

doi 10.3389/fmolb.2024.1385238

2,744 views
2 citations

Original Research

Published on 02 May 2024

TUBB, a robust biomarker with satisfying abilities in diagnosis, prognosis, and immune regulation via a comprehensive pan-cancer analysis

in Molecular Diagnostics and Therapeutics

Zaifu Zhu
Wei Zhang
Shaohu Huo
Tiantuo Huang
Xi Cao
Ying Zhang

Frontiers in Molecular Biosciences

doi 10.3389/fmolb.2024.1365655

2,039 views

Original Research

Published on 01 May 2024

Improving drinking water quality through proficiency testing—the impact of testing method and accreditation status on Escherichia coli detection by Canadian environmental testing laboratories

in Molecular Diagnostics and Therapeutics

Mahfuza Sreya
Md Saiful Alam
Sahibjot Daula
Caleb Lee
Veronica Restelli
Ken Middlebrook
Michael A. Noble
Lucy A. Perrone

Frontiers in Molecular Biosciences

doi 10.3389/fmolb.2024.1338549

1,100 views

Original Research

Published on 01 May 2024

Unraveling breast cancer prognosis: a novel model based on coagulation-related genes

in Molecular Diagnostics and Therapeutics

Chuqi Lei
Yuan Li
Huaiyu Yang
Ke Zhang
Wei Lu
Nianchang Wang
Lixue Xuan

Frontiers in Molecular Biosciences

doi 10.3389/fmolb.2024.1394585

1,708 views
1 citation

Original Research

Published on 01 May 2024

Comprehensive analysis of juvenile idiopathic arthritis patients’ immune characteristics based on bulk and single-cell sequencing data

in Molecular Diagnostics and Therapeutics

Mubo Liu
Yadong Gong
Mu Lin
Qingqing Ma

Frontiers in Molecular Biosciences

doi 10.3389/fmolb.2024.1359235

1,494 views

Original Research

Published on 30 Apr 2024

MIR4435-2HG as a possible novel predictive biomarker of chemotherapy response and death in pediatric B-cell ALL

in Molecular Diagnostics and Therapeutics

Yulieth Torres-Llanos
Jovanny Zabaleta
Nataly Cruz-Rodriguez
Sandra Quijano
Paula Carolina Guzmán
Iliana de los Reyes
Nathaly Poveda-Garavito
Ana Infante
Liliana Lopez-Kleine
Alba Lucía Combita

Frontiers in Molecular Biosciences

doi 10.3389/fmolb.2024.1385140

1,502 views
1 citation

Review

Published on 29 Apr 2024

The potential therapeutic roles of dental pulp stem cells in spinal cord injury

in Molecular Diagnostics and Therapeutics

Jing Fu
Wenjie Li
Tengfei Mao
Zaipeng Chen
Lili Lai
Jiachen Lin
Zhiqiang Nie
Yunkai Sun
Yanqin Chen
Qin Zhang

Frontiers in Molecular Biosciences

doi 10.3389/fmolb.2024.1363838

1,169 views

Original Research

Published on 26 Apr 2024

A prospective study on using shear wave elastography to predict the ypT0 stage of rectal cancer after neoadjuvant therapy: a new support for the watch-and-wait approach?

in Molecular Diagnostics and Therapeutics

Mengjia Liu
Ningyi Cui
Chao Sun
Xuantong Gong
Bo Wang
Di Yang
Yong Wang

Frontiers in Molecular Biosciences

doi 10.3389/fmolb.2024.1402498

817 views

Review

Published on 24 Apr 2024

Modelling esophageal adenocarcinoma and Barrett’s esophagus with patient-derived organoids

in Molecular Diagnostics and Therapeutics

Julia V. Milne
Ebtihal H. Mustafa
Nicholas J. Clemons

Frontiers in Molecular Biosciences

doi 10.3389/fmolb.2024.1382070

1,847 views
2 citations

Perspective

Published on 24 Apr 2024

Harnessing inter-kingdom metabolic disparities at the human-fungal interface for novel therapeutic approaches

in Molecular Diagnostics and Therapeutics

Claudio Costantini
Marilena Pariano
Matteo Puccetti
Stefano Giovagnoli
Gioena Pampalone
Mirco Dindo
Barbara Cellini
Luigina Romani

Frontiers in Molecular Biosciences

doi 10.3389/fmolb.2024.1386598

975 views

Correction

Published on 24 Apr 2024

Corrigendum: Evaluation of PIK3CA mutations in advanced ER+/HER2-breast cancer in Portugal – U-PIK Project

in Molecular Diagnostics and Therapeutics

Ana Peixoto
Luís Cirnes
Ana Luísa Carvalho
Maria João Andrade
Maria José Brito
Paula Borralho
Nuno Coimbra
Pedro M. Borralho
Ana Sofia Carneiro
Lisandra Castro

Frontiers in Molecular Biosciences

doi 10.3389/fmolb.2024.1298522

750 views

Navigation group

Articles

Corrigendum: Mechanotransductive receptor Piezo1 as a promising target in the treatment of fibrosis diseases

MicroRNA as a promising molecular biomarker in the diagnosis of breast cancer

Circulating microRNAs as promising diagnostic biomarkers for hepatocellular carcinoma: a systematic review and meta-analysis

Next generation single-domain antibodies against respiratory zoonotic RNA viruses

Multikinase inhibitors modulate non-constitutive proteasome expression in colorectal cancer cells

Prospects of liquid biopsy in the prognosis and clinical management of gastrointestinal cancers

TUBB, a robust biomarker with satisfying abilities in diagnosis, prognosis, and immune regulation via a comprehensive pan-cancer analysis

Improving drinking water quality through proficiency testing—the impact of testing method and accreditation status on Escherichia coli detection by Canadian environmental testing laboratories

Unraveling breast cancer prognosis: a novel model based on coagulation-related genes

Comprehensive analysis of juvenile idiopathic arthritis patients’ immune characteristics based on bulk and single-cell sequencing data

MIR4435-2HG as a possible novel predictive biomarker of chemotherapy response and death in pediatric B-cell ALL

The potential therapeutic roles of dental pulp stem cells in spinal cord injury

A prospective study on using shear wave elastography to predict the ypT0 stage of rectal cancer after neoadjuvant therapy: a new support for the watch-and-wait approach?

Modelling esophageal adenocarcinoma and Barrett’s esophagus with patient-derived organoids

Harnessing inter-kingdom metabolic disparities at the human-fungal interface for novel therapeutic approaches

Corrigendum: Evaluation of PIK3CA mutations in advanced ER+/HER2-breast cancer in Portugal – U-PIK Project